Companies / Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

Nasdaq: FENCCIK 1211583RESEARCH TRIANGLE PARK, NC

Financials · FY2025

Revenue$44.64M
Net income$-9.74M
Total debt$19.38M
Cash$41.25M
Diluted EPS$-0.34
Shares outstanding34.7M

Ownership

34.7M shares outstanding · as of May 12, 2026
1.8%Insiders
Ownership
Insiders1.76%611,456
10%+ / strategic5.70%1,981,501
Institutions49.63%17,239,566
Public float42.91%14,904,507

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Andrade RobertCHIEF FINANCIAL OFFICER
0.83%289,269
Raykov RostyDirector
0.37%130,079
Rallis Chris aDirector
0.18%63,077
Hackman Jeffrey S.CEOChief Executive Officer · Director
0.18%62,825
Cioffi Christiana MarieChief Strategy Officer
0.07%24,176
Evans Terry LChief Commercial Officer
0.06%21,015
Sayad Pierre SargisChief Medical Officer
0.06%21,015
Brughera Marco MariaDirector
——
Cook Jodi ADirector
——
Islam KhalidDirector
——

Institutional holders 100

View all →
HolderValue% of shares
AIGH Capital Management LLC$26.72M7.16%
Rosalind Advisors, Inc.$20.12M7.52%
Solas Capital Management, LLC$19.72M7.37%
BlackRock, Inc.$18.57M4.97%
Southpoint Capital Advisors LP$16.88M7.90%
Vanguard Group Inc$8.22M3.07%
AWM Investment Company, Inc.$5.48M2.05%
State Street Corporation$4.58M1.23%
Geode Capital Management, LLC$2.29M1.07%
Morgan Stanley$1.87M0.70%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 1, 2026Raykov Rosty
Director
SellCommon shares$93.8K-10K
-6.97%
130,079
0.37% of shares
low
Mar 2, 2026Raykov Rosty
Director
SellCommon shares$84.3K-10K
-8.84%
103,996
0.30% of shares
low
Feb 2, 2026Raykov Rosty
Director
SellCommon shares$80.3K-10K
-9.51%
98,477
0.28% of shares
low
Jan 2, 2026Raykov Rosty
Director
SellCommon shares$78.4K-10K
-10.49%
88,020
0.25% of shares
low
May 1, 2026Raykov Rosty
Director
SellCommon shares$69.8K-11K
-8.15%
121,451
0.35% of shares
low
Apr 1, 2026Raykov Rosty
Director
SellCommon shares$69.1K-11K
-8.77%
113,856
0.33% of shares
low
Mar 26, 2026Andrade Robert
Executive
ExerciseCommon shares$66.7K+13K
+5.37%
256,656
0.74% of shares
low
May 11, 2026Rallis Chris a
Director
SellCommon Shares$58.8K-8K
-11.69%
63,077
0.18% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Southpoint Capital Advisors LPPassive13G/A———
Rosalind Advisors, Inc.Passive13G/A———
Sonic Fund II, L.P.Passive13G/A———
Orin HirschmanPassive13G—1,981,501—
Rosalind Advisors, Inc.Passive13G/A———
Solas Capital Management, LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
FENC——31447P100—